Skip to main content

Table 1 Characteristics of 63 pancreas cancer patients

From: Intensity modulated radiotherapy for locally advanced and metastatic pancreatic cancer: a mono-institutional retrospective analysis

Characteristics No. of patients, n = 63
Sex  
  Male 43 (68.3%)
  Female 20 (31.7%)
Age (Median) 62 (40–82)
Stage  
  Locally advanced 31 (49.2%)
  Metastatic 32 (50.8%)
Tumor location  
  Head 23 (36.5%)
  Body/tail 40 (63.5%)
Tumor size* (median) 4.6 cm (2.5 cm - 9.3 cm)
Diagnostic mode  
  Histological/cytological 45 (71.4%)
  Clinical 18 (28.6%)
CA19–9 at diagnosis  
  ≥ 1000 U/ml 25 (39.7%)
  < 1000 U/ml 33 (52.4%)
  Missing 5 (7.9%)
CEA at diagnosis  
  >10 ng/ml 13 (20.6%)
  ≤10 ng/ml 41 (65.1%)
  Missing 9 (14.3%)
Concurrent chemotherapy  
  Yes 27 (42.9%)
  No 36 (57.1%)
Systemic chemotherapy  
  Yes 26 (41.3%)
  No 37 (58.7%)
RIAC  
  Yes 39 (61.9%)
  No 24 (38.1%)
  1. *Maximum diameter of the primary tumor.
  2. CA19-9 carbohydrate antigen 19–9, CEA carcinoembryonic antigen, RIAC regional intra-arterial chemotherapy.